Stocktoria
CHEMED CORP CHE
CHEMED CORP financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.4B | $2.3B | $2.1B | $2.1B | $2.1B | $1.9B | $1.8B | $1.7B | $1.6B |
| SG&A expense | $417.2M | $424.4M | $395.1M | $358.7M | $366.7M | $330.2M | $305.7M | $271.2M | $276.7M | $243.6M |
| Operating income | $338.2M | $366.5M | $340.6M | $343.5M | $343.0M | $389.7M | $257.4M | $243.6M | $113.0M | $178.7M |
| Interest expense | $1.8M | $1.8M | $3.1M | $4.6M | $1.9M | $2.4M | $4.5M | $5.0M | $4.3M | $3.7M |
| Income tax | $90.5M | $97.5M | $77.9M | $80.1M | $81.8M | $76.5M | $41.7M | $34.1M | $18.7M | $68.3M |
| Net income | $265.2M | $302.0M | $272.5M | $249.6M | $268.6M | $319.5M | $219.9M | $205.5M | $98.2M | $108.7M |
| EPS (diluted) | $18.34 | $19.89 | $17.93 | $16.53 | $16.85 | $19.48 | $13.31 | $12.23 | $5.86 | $6.48 |
| Operating cash flow | $388.3M | $417.5M | $330.3M | $309.9M | $308.6M | $489.3M | $301.2M | $287.1M | $162.5M | $135.4M |
| Free cash flow | $325.5M | $368.0M | $273.4M | $252.6M | $249.9M | $430.5M | $248.2M | $234.3M | $98.2M | $95.6M |
| Cash & equivalents | $74.5M | $178.3M | $264.0M | $74.1M | $32.9M | $162.7M | $6.2M | $4.8M | $11.1M | $15.3M |
| Inventory | $7.5M | $8.2M | $12.0M | $10.3M | $10.1M | $7.1M | $7.5M | $5.7M | $5.3M | $5.8M |
| Total assets | $1.5B | $1.7B | $1.7B | $1.4B | $1.3B | $1.4B | $1.3B | $975.5M | $920.0M | $880.1M |
| Total liabilities | $558.8M | $549.6M | $560.2M | $643.3M | $719.5M | $533.7M | $541.7M | $384.2M | $379.7M | $356.0M |
| Shareholders' equity | $979.4M | $1.1B | $1.1B | $798.7M | $623.3M | $901.2M | $726.6M | $591.3M | $540.4M | $524.1M |
Growth · year-over-year · Revenue CAGR 5.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +4.1% | +7.4% | +6.1% | -0.2% | +2.9% | +7.3% | +8.7% | +7.0% | +5.7% | +2.2% |
| Net income growth | -12.2% | +10.8% | +9.2% | -7.0% | -15.9% | +45.3% | +7.0% | +109.4% | -9.7% | -1.4% |
| EPS growth | -7.8% | +10.9% | +8.5% | -1.9% | -13.5% | +46.4% | +8.8% | +108.7% | -9.6% | +2.4% |
| Free cash flow growth | -11.5% | +34.6% | +8.3% | +1.1% | -41.9% | +73.4% | +6.0% | +138.6% | +2.7% | -24.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.